PharmTech News

Articles

The pharma major will spin out six molecules in early stage inflammation and autoimmune programs into a new company called Viela Bio.

AstraZeneca to Create Independent Biotech Spin-Off

A jury verdict requiring Gilead Sciences to pay $2.54 billion for patent infringement to competitor Merck & Co. over Gilead's Harvoni (ledipasvir and sofosbuvir) and Sovaldi (sofosbuvir), two best-selling hepatitis C drugs, has been overturned.

Gilead Wins Reversal of $2.54-Billion Hep C Patent Verdict

Roche will acquire oncology-focused healthcare technology and services company Flatiron Health for $1.9 billion to further its personalized oncological healthcare strategy.

Roche to Acquire Flatiron Health for $1.9 Billion

A $800-million acquisition of MPI Research expands Charles River's offerings for early-stage contract research. 

Charles River Laboratories Acquires MPI Research

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

The President described US drug costs as unfair and stated that prices will come down.

Trump Blasts Drug Prices, Sidesteps Health Reform

The acquisition will strengthen Sanofi's R&D strategy and expands its franchise for rare blood disorders.

Sanofi to Acquire Ablynx in $4.8-Billion Deal

The acquisition would boost Sanofi's position in hematology and specialty medicines.

Sanofi to Acquire Biogen Spin-Off in $11.6-Billion Deal

The latest continuing resolution funds the government for three weeks.

FDA Heads Back to Work, for Now

Non-essential activities and new regulatory submissions are on hold until a federal government funding agreement is reached.

Government Shutdown Closes Down Some FDA Work

Frustrated with chronic shortages and high costs, hospitals form their own generic drug company.

Top News